Complete response to cetuximab plus paclitaxel therapy in
nivolumab-refractory patients in distant metastasis of squamous cell
carcinoma of the tongue: a report of two cases
- Hidetake Tachinami
, - Kei Tomihara,
- Danki Takatsuka,
- Atsushi Ikeda,
- Shin-ichi Yamada,
- Makoto Noguchi
Hidetake Tachinami
University of Toyama Faculty of Medicine Graduate School of Medicine and Pharmaceutical Science for Education
Corresponding Author:[email protected]
Author ProfileKei Tomihara
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author ProfileAtsushi Ikeda
University of Toyama Faculty of Medicine Graduate School of Medicine and Pharmaceutical Science for Education
Author ProfileAbstract
Herein, we report two cases of patients diagnosed with
nivolumab-refractory distant metastatic squamous cell carcinoma of the
tongue who were successfully treated with a combination of paclitaxel
and cetuximab, thus demonstrating that some nivolumab-refractory
patients with recurrent or distant metastatic oral squamous cell
carcinoma may benefit from subsequent salvage chemotherapy.
